knowledge -WSS

knowledge

author：knowledge 2025-10-01 21:09:36 - browse：4533

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The high cost of giving birth even with insurance
Next article： Eli Lilly expects to double planned employment in Boston center

knowledge

WSS

How climate

Impact of Dobbs ruling felt at reproductive medicine meeting

First Opinion Podcast: Long Covid needs a new approach

Prosthetic arm enables patients to feel the objects they grip

First Opinion Podcast: Long Covid needs a new approach

Lab trade group sues FDA to halt regulation of lab

leisure time

knowledge

focus

After affirmative action ruling, medical educators look to 'holistic review'

Startling documents reveal new facets of Sacklers' opioid empire

Apple is now the first public company to be valued at $3 trillion

STAT Summit: How a Chicago ER doctor tackles gun violence

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What will save rural psychiatry services? Higher Medicaid payments

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Solve the antibiotic resistance crisis with preventive drugs

Duchenne breakthrough therapy leaves behind pioneering families

David Sabatini, ex

focus

FDA gives detailed accounting of AI

Addiction doctors spar with methadone clinics over legislation

Prosthetic arm enables patients to feel the objects they grip

Hospital price transparency does save money, advocate argues

Pharmacists can make shortage drugs, but at what cost?

The EU Joint Clinical Assessment needs to live up to its promise

knowledge

hotspot

explore

explore